This deal aims to leverage Lesaffre's and Biorigin's complementary capabilities to enable enhanced yeast derivative and savoury ingredient solutions for customers worldwide
Lesaffre, an independent key global player in fermentation and microorganisms, announced the acquisition of a majority stake in Biorigin, a business unit of Zilor, a multinational company producing yeast derivative products, to enhance the supply of yeast derivatives for savoury ingredients. The cooperation will improve production processes, logistics and services to the benefit of a global customer base.
As a result of the deal, Lesaffre will become the controlling shareholder of Biorigin with 70 per cent of its total corporate capital, while Zilor will remain a shareholder with 30 per cent. The deal includes Biorigin's production unit in Quatá/São Paulo, an industrial plant, based in the attractive country of Brazil where there are abundant sugar, water and renewable energy resources.
This deal aims to leverage Lesaffre's and Biorigin's complementary capabilities to enable enhanced yeast derivative and savoury ingredient solutions for customers worldwide. The business combination between Lesaffre and Biorigin will offer customers benefits by upgrading production capacity and new solutions based on the production and marketing of naturally derived ingredients for human food and animal nutrition industries.
